NDC 66220-812

RediTrex

Methotrexate

RediTrex is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Cumberland Pharmaceuticals Inc.. The primary component is Methotrexate.

Product ID66220-812_27143f5b-2401-425a-b0b9-98200d947a35
NDC66220-812
Product TypeHuman Prescription Drug
Proprietary NameRediTrex
Generic NameMethotrexate
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-07-01
Marketing CategoryNDA / NDA
Application NumberNDA210737
Labeler NameCumberland Pharmaceuticals Inc.
Substance NameMETHOTREXATE
Active Ingredient Strength13 mg/.5mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 66220-812-22

4 CARTON in 1 CASE (66220-812-22) > 1 SYRINGE in 1 CARTON (66220-812-11) > .5 mL in 1 SYRINGE
Marketing Start Date2020-07-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "RediTrex" or generic name "Methotrexate"

NDCBrand NameGeneric Name
66220-815RediTrexRediTrex
66220-825RediTrexRediTrex
66220-807RediTrexRediTrex
66220-810RediTrexRediTrex
66220-817RediTrexRediTrex
66220-812RediTrexRediTrex
66220-820RediTrexRediTrex
66220-822RediTrexRediTrex
0143-9367MethotrexateMethotrexate
0143-9516MethotrexateMethotrexate
0143-9517MethotrexateMethotrexate
0143-9518MethotrexateMethotrexate
0143-9519MethotrexateMethotrexate
0143-9830MethotrexateMethotrexate
0378-0014Methotrexatemethotrexate
0555-0572MethotrexateMethotrexate
0703-3671MethotrexateMethotrexate
0703-3675MethotrexateMethotrexate
0703-3678MethotrexateMethotrexate

Trademark Results [RediTrex]

Mark Image

Registration | Serial
Company
Trademark
Application Date
REDITREX
REDITREX
87700133 not registered Live/Pending
Cumberland Pharmaceuticals Inc.
2017-11-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.